YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지
DOI QR코드

DOI QR Code

Tiering 'Drug Combinations to Avoid' and 'Drug-age Precaution' DUR Alerts by Severity Level and its Application

병용금기, 연령금기 경고 등급화 방안과 DUR 처방변경률 분석

  • Lee, Soo Ok (College of Pharmacy, Pusan National University) ;
  • Je, Nam Kyung (College of Pharmacy, Pusan National University) ;
  • Kim, Dong-Sook (Research Team, Health Insurance Review & Assessment Service) ;
  • Cheun, Bang Ok (Research Team, Health Insurance Review & Assessment Service) ;
  • Hwang, In Ok (Research Team, Health Insurance Review & Assessment Service)
  • 이수옥 (부산대학교 약학대학) ;
  • 제남경 (부산대학교 약학대학) ;
  • 김동숙 (건강보험심사평가원 연구조정실) ;
  • 천방옥 (건강보험심사평가원 연구조정실) ;
  • 황인옥 (건강보험심사평가원 연구조정실)
  • Received : 2015.09.06
  • Accepted : 2015.11.11
  • Published : 2015.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

The computerized prospective Drug Utilization Review (DUR) program supported by the Korean government has provided alerts to physicians and pharmacists since December 2010. This study aims to propose and apply the tiering system in "drug combinations to avoid (DCA)" and "age-precaution" alerts based on severity to improve the compliance of users. To propose the severity and clinical importance of 647 DCA alerts and 140 age precautions, a Delphi evaluation survey was conducted. An expert panel comprising 5 clinical pharmacists and 5 physicians were participated in mail surveys. Based on the results of Delphi survey, DCA pairs were classified into 3 groups; group 1 (70.6%), 2 (26.9%), and 3 (2.8%). Drug-age precaution ingredients were also classified into three groups; group 1 (53.6%), group 2 (40.7%), and group 3 (5.7%). When this grouping was applied to claim data from 2011 to 2013, the majority of alerts had occurred in the groups of high severity. Presenting DUR alerts with severity level is expected to improve the compliance of clinicians. The implementation of tiering system in DUR criteria should be considered.

Keywords

References

  1. 건강보험심사평가원 : 의약품 처방조제지원서비스(DUR) 매뉴얼. (2013.12).
  2. 김동숙, 강현아, 전하림, 박주희, 박찬미, 이나미, 제남경 : DUR 효과측정 및 활용방안에 대한 연구, 건강보험심사평가원 (2014).
  3. 이하영, 권용진 : 의약품 리베이트의 원인과 처방에 관한 신제도론적 해석. 보건행정학회지 21, 132 (2011).
  4. Fulda, T. R., Lyles, A., Pugh, M. C. and Christensen, D. B. : Current status of prospective drug utilization review. J Manag. Care Pharm. 10, 433 (2004).
  5. Paterno, M. D., Maviglia, S. M., Gorman, P. N., Seger, D. L., Yoshida, E., Seger, A. C., Bates, D. W. and Gandhi, T. K. : Tiering drug-drug interaction alerts by severity increases compliance rates. J. Am. Med. Inform. Assoc. 16, 40 (2009). https://doi.org/10.1197/jamia.M2808
  6. 김동숙, 장수현, 배승진, 이병란, 최혜린 : 약제심사제도 선진화 방안 연구 - DUR 제도 발전방안을 중심으로, 건강보험심사평가원 (2010).
  7. Isaac, T., Weissman, J. S., Davis, R. B., Massagli, M., Cyrulik, A., Sands, D. Z. and Weingart, S. N. : Overrides of medication alerts in ambulatory care. Arch. Intern. Med. 169, 305 (2009). https://doi.org/10.1001/archinternmed.2008.551
  8. Weingart, S. N., Toth, M., Sands, D. Z., Aronson, M. D., Davis, R. B. and Phillips, R. S. : Physicians' decisions to override computerized drug alerts in primary care. Arch. Intern. Med. 163, 2625 (2003). https://doi.org/10.1001/archinte.163.21.2625
  9. Lexi-Comp $Online^{TM}$, Hudson, OH: Lexi-Comp, Inc. Updated periodically. Accessed June 01 (2015).
  10. $Micomedex^{(R)}$ Healthcare Services. Greenwood Village, CO: Truven Health Analytics, Inc. Updated periodically. Accessed June 01 (2015).
  11. Armstrong, E. P. and Denemark, C. R. : How pharmacists respond to on-line, real-time dur alerts. J. Am. Pharm. Assoc. 38, 149 (1998). https://doi.org/10.1016/S1086-5802(16)30314-X
  12. van der Sijs, H., Mulder, A., van Gelder, T., Aarts, J., Berg, M. and Vulto, A. : Drug safety alert generation and overriding in a large Dutch university medical centre. Pharmacoepidemiol. Drug Saf. 18, 941(2009). https://doi.org/10.1002/pds.1800